Recommended

FDA tightens COVID vaccine use
Decentralised manufacturing consortium launched
Trial boost for myasthenia gravis drug
FDA starts publishing daily AE data
WEBINAR | The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology | 5 NOV
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT
news

Generics propelling pharmaceutical parenteral packaging market

2
SHARES

Preference for small molecule prefilled syringes and a greater demand for prefilled insulin syringes for diabetes is driving growth of the pharmaceutical parenteral packaging market, a report states.

pharmaceutical parenteral packaging market

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Ltd. has predicted that the sector will value $18.85 billion by 2031. This is aligned with a CAGR of 4.47 percent between 2024 and 2031.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for generic medicines will be a significant factor for growth.

Additionally, advances in technology and a rising prevalence of chronic diseases were described as two factors that are helping to boost the market.

Pharmaceutical suspension market to witness accelerated growth

prefilled syringes will hold a “significant” share of the global market”

In terms of parenteral packaging type, the report expected that prefilled syringes will hold a “significant” share of the global market. This is due to several influences including ease of use, which supports reduced number of dose errors. Furthermore, industry preference for prefilled syringes for small molecule treatments is also driving the sector. Due to the increasing prevalence of diabetes worldwide, greater demand for prefilled insulin syringes is predicted to be a major contributor to its expansion, the report asserted.

Regionally, North America is anticipated to hold a major portion of the pharmaceutical parenteral packaging market, according to the report. This is considering its prediction that the market will witness “a high CAGR in the near future” due to factors such as higher demand for injectable medicine packaging. Otherwise, the research observed that Europe had a “substantial” market share due for instance, expanded vaccine programmes.

Pharmaceutical parenteral packaging market challenges

However, key challenges concerning future growth of the sector were reported to include strict regulations. This is because it causes innovation to slow and heightens expenses for manufacturers. Moreover, the high cost of raw materials eg, glass and plastic, which “can fluctuate significantly” were also noted as obstacles.

Based on the report, key players within the pharmaceutical parenteral packaging market include West Pharmaceutical Services, Inc., Catalent Inc. and PCI Pharma Services.

Share via
Share via